Nalaganje...
An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation
Increasing evidence suggests that signaling through the prolactin/prolactin receptor axis is important for stimulation the growth of many cancers including glioblastoma multiforme, breast and ovarian carcinoma. Efficient inhibitors of signaling have previously been developed but their applicability...
Shranjeno v:
| izdano v: | PLoS One |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Public Library of Science
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6504076/ https://ncbi.nlm.nih.gov/pubmed/31063493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0215831 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|